Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract B071: Automated extraction and provision of electronic health record data from children with cancer to National Childhood Cancer Center (NCCR) cancer registries

Tamara P. Miller, Johanna Goderre Jones, Elizabeth Hsu, Edward Krause, Yun Gun Jo, Judy Lee, Kevin Ward, Lynne Penberthy, Richard Aplenc

Cancer Res (2024) 84 (17_Supplement): B071.

https://doi.org/10.1158/1538-7445.PEDIATRIC24-B071

Published: 05 September 2024

View article titled, Abstract B071: Automated extraction and provision of electronic health record data from children with cancer to National Childhood Cancer Center (NCCR) cancer registries

Journal Articles

Abstract 3479: UBTF tandem duplications (UBTF-TD) in childhood AML: Enrichment in FLT3-ITD and association with clinical outcome

Leila Robinson, Amanda Leonti, Todd A. Alonzo, Yi-Cheng Wang, Michele S. Redell, Rhonda E. Ries, Jenny L. Smith, Tiffany A. Hylkema, Quy Le, E Anders Kolb, Richard Aplenc, Xiaotu Ma, Jeffrey Klco, Katherine Tarlock, Soheil Meshinchi

Cancer Res (2022) 82 (12_Supplement): 3479.

https://doi.org/10.1158/1538-7445.AM2022-3479

Published: 15 June 2022

View article titled, Abstract 3479: UBTF tandem duplications (UBTF-TD) in childhood AML: Enrichment in FLT3-ITD and association with clinical outcome

Journal Articles

Abstract 5120: Surveying the AML surfaceome for novel immunotherapeutic targets

Tina Glisovic-Aplenc, Kevin Nestler, Congcong Lu, Lusha Cao, Joseph Cesare, Hyoungjoo Lee, Mitchelle Matesva, Terzah Horton, Sarah Tasian, John Shern, Saar Gill, Benjamin Garcia, Richard Aplenc

Cancer Res (2020) 80 (16_Supplement): 5120.

https://doi.org/10.1158/1538-7445.AM2020-5120

Published: 15 August 2020

View article titled, Abstract 5120: Surveying the AML surfaceome for novel immunotherapeutic targets

Journal Articles

Abstract 1921: The DDB2 intronic variation rs830083 is a strong predictor of gemtuzumab ozogamicin response in AML patients: A calicheamicin pathway-directed analysis from the COG-AAML0531 trial

Vivek M. Shastri, Lata Chauhan, Todd A. Alonzo, Yi-Cheng Wang, Richard Aplenc, Betsy A. Hirsch, Alan S. Gamis, Soheil Meshinchi, Jatinder K. Lamba

Cancer Res (2020) 80 (16_Supplement): 1921.

https://doi.org/10.1158/1538-7445.AM2020-1921

Published: 15 August 2020

View article titled, Abstract 1921: The DDB2 intronic variation rs830083 is a strong predictor of gemtuzumab ozogamicin response in AML patients: A calicheamicin pathway-directed analysis from the COG-AAML0531 trial

Journal Articles

Abstract 451: Proteomic profiling of the unfolded protein response identifies patients benefiting from bortezomib in pediatric acute myeloid leukemia

Fieke W. Hoff, Yihua Qiu, Wendy Hu, Amina A. Qutub, Alon S. Gamis, Richard Aplenc, E Anders Kolb, Todd A. Alonzo, Eveline SJM de Bont, Steven M. Kornblau, Terzah Horton

Cancer Res (2018) 78 (13_Supplement): 451.

https://doi.org/10.1158/1538-7445.AM2018-451

Published: 01 July 2018

View article titled, Abstract 451: Proteomic profiling of the unfolded protein response identifies patients benefiting from bortezomib in pediatric acute myeloid leukemia

Journal Articles

Abstract 2699: Proteomic landscape of de novo pediatric acute myeloid leukemia

Fieke W. Hoff, Yihua Qiu, Wendy Hu, Amina A. Qutub, Alan S. Gamis, Richard Aplenc, E Anders Kolb, Todd A. Alonzo, Eveline SJM de Bont, Terzah M. Horton, Steven M. Kornblau

Cancer Res (2018) 78 (13_Supplement): 2699.

https://doi.org/10.1158/1538-7445.AM2018-2699

Published: 01 July 2018

View article titled, Abstract 2699: Proteomic landscape of de novo pediatric acute myeloid leukemia

Journal Articles

Abstract 4884: Focal 22q11.22 deletions combined with IKZF1 alterations are associated with worse clinical outcome in acute lymphoblastic leukemia

Julia A. Meyer, Clint C. Mason, Luke Maese, Deqing Pei, Cheng Cheng, Ching-Hon Pui, Mel Greaves, Richard Aplenc, Charles G. Mulligan, Elizabeth Raetz, Rodney R. Miles, Karen R. Rabin, Joshua D. Schiffman

Cancer Res (2017) 77 (13_Supplement): 4884.

https://doi.org/10.1158/1538-7445.AM2017-4884

Published: 01 July 2017

View article titled, Abstract 4884: Focal 22q11.22 deletions combined with IKZF1 alterations are associated with worse clinical outcome in acute lymphoblastic leukemia

Journal Articles

Abstract PR06: T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 (CTL019) produce complete responses and long-term persistence without GVHD in children with relapsed, refractory ALL

Stephan A. Grupp, Shannon Maude, Richard Aplenc, David M. Barrett, Michael Kalos, Bruce Levine, Manuel Lichtman, Susan Rheingold, Angela Shen, Christine Strait, David Teachey, Patricia A. Wood, Carl June

Cancer Res (2014) 74 (20_Supplement): PR06.

https://doi.org/10.1158/1538-7445.PEDCAN-PR06

Published: 09 October 2014

View article titled, Abstract PR06: T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 (CTL019) produce complete responses and long-term persistence without GVHD in children with relapsed, refractory ALL

Journal Articles

Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer

Angela DeMichele, Robert Gray, Michelle Horn, Jinbo Chen, Richard Aplenc, William P. Vaughan, Martin S. Tallman

Cancer Res (2009) 69 (10): 4184–4191.

https://doi.org/10.1158/0008-5472.CAN-08-2989

Published: 15 May 2009

View article titled, Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer

Includes: Supplementary data

Journal Articles

Joint effects of CYP3A4, CYP3A5, CYP3A43, SRD5A2 and AR genotypes in the etiology and severity of prostate cancer

Charnita M. Zeigler-Johnson, Amy Walker, Elaine Spangler, Saarene Panossian, Margerie Patacsil-Coomes, Thomas O’Brien, Richard Aplenc, Bruce Malkowicz, Timothy Rebbeck

Cancer Res (2006) 66 (8_Supplement): 863.

Published: 15 April 2006

View article titled, Joint effects of CYP3A4, CYP3A5, CYP3A43, SRD5A2 and AR genotypes in the etiology and severity of prostate cancer

Journal Articles

Methylenetetrahydrofolate Reductase Polymorphisms and Therapy Response in Pediatric Acute Lymphoblastic Leukemia

Richard Aplenc, Jennifer Thompson, Peggy Han, Mei La, Huaqing Zhao, Beverly Lange, Timothy Rebbeck

Cancer Res (2005) 65 (6): 2482–2487.

https://doi.org/10.1158/0008-5472.CAN-04-2606

Published: 21 March 2005

View article titled, Methylenetetrahydrofolate Reductase Polymorphisms and Therapy Response in Pediatric Acute Lymphoblastic Leukemia

Journal Articles

CYP3A4 , CYP3A5 , and CYP3A43 Genotypes and Haplotypes in the Etiology and Severity of Prostate Cancer

Charnita Zeigler-Johnson, Tara Friebel, Amy H. Walker, Yiting Wang, Elaine Spangler, Saarene Panossian, Margerie Patacsil, Richard Aplenc, Alan J. Wein, S. Bruce Malkowicz, Timothy R. Rebbeck

Cancer Res (2004) 64 (22): 8461–8467.

https://doi.org/10.1158/0008-5472.CAN-04-1651

Published: 17 November 2004

View article titled, CYP3A4 , CYP3A5 , and CYP3A43 Genotypes and Haplotypes in the Etiology and Severity of Prostate Cancer

Journal Articles

Cytoplasmic μ Heavy Chain Confers Sensitivity to Dexamethasone-induced Apoptosis in Early B-lineage Acute Lymphoblastic Leukemia

Jenny M. Kim, Junjie Fang, Susan Rheingold, Richard Aplenc, Robert Wasserman, Stephan A. Grupp

Cancer Res (2002) 62 (15): 4212–4216.

Published: 01 August 2002

View article titled, Cytoplasmic μ Heavy Chain Confers Sensitivity to Dexamethasone-induced Apoptosis in Early B-lineage Acute Lymphoblastic Leukemia

NARROW

Abstract B071: Automated extraction and provision of electronic health record data from children with cancer to National Childhood Cancer Center (NCCR) cancer registries

Abstract 3479: UBTF tandem duplications (UBTF-TD) in childhood AML: Enrichment in FLT3-ITD and association with clinical outcome

Abstract 5120: Surveying the AML surfaceome for novel immunotherapeutic targets

Abstract 1921: The DDB2 intronic variation rs830083 is a strong predictor of gemtuzumab ozogamicin response in AML patients: A calicheamicin pathway-directed analysis from the COG-AAML0531 trial

Abstract 451: Proteomic profiling of the unfolded protein response identifies patients benefiting from bortezomib in pediatric acute myeloid leukemia

Abstract 2699: Proteomic landscape of de novo pediatric acute myeloid leukemia

Abstract 4884: Focal 22q11.22 deletions combined with IKZF1 alterations are associated with worse clinical outcome in acute lymphoblastic leukemia

Abstract PR06: T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 (CTL019) produce complete responses and long-term persistence without GVHD in children with relapsed, refractory ALL

Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer

Joint effects of CYP3A4, CYP3A5, CYP3A43, SRD5A2 and AR genotypes in the etiology and severity of prostate cancer

Methylenetetrahydrofolate Reductase Polymorphisms and Therapy Response in Pediatric Acute Lymphoblastic Leukemia

CYP3A4 , CYP3A5 , and CYP3A43 Genotypes and Haplotypes in the Etiology and Severity of Prostate Cancer

Cytoplasmic μ Heavy Chain Confers Sensitivity to Dexamethasone-induced Apoptosis in Early B-lineage Acute Lymphoblastic Leukemia

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only